Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of<scp><i>APP</i></scp>Dose and Preclinical Studies of a γ‐Secretase Modulator
Xu‐Qiao Chen(University of California San Diego), William C. Mobley(University of California San Diego)
Cited by 12
Related Papers
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483
Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I
|Molecular Genetics and Metabolism|2004|168
CaMKIIα and caveolin-1 cooperate to drive ATP-induced membrane delivery of the P2X3 receptor
|Journal of Molecular Cell Biology|2014|18